TY - JOUR
T1 - Effectiveness and safety of switching IBD patients from the originator to the biosimilar infliximab
AU - Strik, Anne S.
AU - Dreesen, Erwin
AU - Samaan, Mark
AU - Gecse, Krisztina
AU - Matheeuwsen, Mijntje
AU - Berends, Sophie
AU - D'Haens, Geert
PY - 2018
Y1 - 2018
N2 - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: The objective of the review is to evaluate whether switching IBD patients from the originator to the biosimilar IFX is safe and effective in patients with quiescent IBD receiving maintenance therapy.
AB - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: The objective of the review is to evaluate whether switching IBD patients from the originator to the biosimilar IFX is safe and effective in patients with quiescent IBD receiving maintenance therapy.
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85049563302&origin=inward
U2 - https://doi.org/10.1002/14651858.CD013068
DO - https://doi.org/10.1002/14651858.CD013068
M3 - Article
SN - 1464-780X
VL - 2018
JO - Cochrane database of systematic reviews (Online)
JF - Cochrane database of systematic reviews (Online)
IS - 7
M1 - CD013068
ER -